Slimquick
Slimquick, licence 80041702: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Slimquick
- NPN or DIN-HM
- 80041702
- Status
- Inactive licence
- Licence date
- 16 April 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium macrocarpon Source : Fruit | 25.0 mg | Not calculated |
| Curcuma longa Source : Racine | 10.0 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 17.25 % Epigallocatechin 3-gallate | 200.0 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 8.5 % Caffeine | Not specified | Not calculated |
| Panax ginseng Source : Racine | 100.0 mg | Not calculated |
| 1,3,7-Triméthylxanthine Source : Caféine | 16.7 mg | Not calculated |
| Iode Source : Iodure de potassium | 25.0 mcg | 150 µg |
| Calcium Source : Carbonate de calcium | 50.0 mg | 300,000 µg |
Non-medicinal ingredients
Acide stéarique, Acésulfame potassium, Stéarate de magnésium, Silice, Dioxyde de titane, Croscarmellose de sodium, Cellulose microcristalline, Poly(éthylène glycol), Hypromellose, Hydroxypropylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Comprimé | 2.0 Tous les jours |
Uses authorised in Canada
To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management. A factor in the maintenance of overall health. Supportive therapy for the promotion of healthy glucose levels. Used in herbal medicine to help enhance physical capacity/performance (in cases of physical stress). Helps the body to metabolize carbohydrates, fat and protein. Supports bone health. Helps in the function of the thyroid gland. Used in herbal medicine as a hormone normalizer to help stabilize menstrual cycle irregularities. Source of antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner before using this product if you have been treated for or diagnosed with, or have a family history of any medical condition including, but not limited to diabetes, liver disorders, iron deficiency, or kidney stones, or if you are taking blood thinners like warfarin, antidepressant medications, digoxin, hormone containing medications such as progesterone preparations, oral contraceptives, or hormone replacement therapy, or any other prescription drug or over-the-counter medication. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synyphrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increases blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended). This product is not intended as a substitute for sleep. Hypersensitivity/allergy is known to occur, in which case, discontinue use. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
- Effets indésirables connus
Some people may experience insomnia, anxiety or headaches, in which case discontinue use. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally).
Source
Official Health Canada record, licence 80041702
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.